Stock search

Ticker or company name

Compare stocks

Market: US

  • ABBVAbbVie
  • AMGNAmgen
  • GILDGilead Sciences

Add stock

Ticker or company

Summary

ABBV
AbbVie
$294,55Down −0,16%
Year: Up +27%
72/100Best scoreRatio would consider buying
Open stock page
AMGN
Amgen
$462,32Down −0,72%
Year: Up +39%
67/100Ratio would watch
Open stock page
GILD
Gilead Sciences
$167,58Down −0,30%
Year: Up +34%
25/100Ratio would not consider buying
Open stock page

Verdict

ABBV has the best score (72). ABBV grows revenue the fastest. ABBV is the cheapest by forward P/E. ABBV has the lowest debt load. AMGN has the highest net margin. GILD has 5 of 10 checks in the red zone.

Verdict by our methodology based on current metrics. Not an investment recommendation.

Traffic light — 10 checks

CheckABBV5 ✓ 3 — 1 ✕AMGN4 ✓ 4 — 1 ✕GILD1 ✓ 2 — 5 ✕
P/E vs its history50,426,8—
P/E vs industry50,426,8—
Forward P/E18,719,2n/a20,9
Revenue growth, YoY+10,7%+8,2%+6,5%
EPS growth, YoY+340,2%+33,3%—
Net margin15,7%24,1%−12,5%
Net debt / EBITDA−0,52,4—
Free cash flow$18,9 bn$9,58 bn$13,8 bn
Share count over a year0,0%+0,7%−0,2%
Cash runwayn/anot neededn/anot neededn/anot needed

Metrics

Best WorstNo mark — in between

Metric · betterABBVTTMAMGNTTMGILDTTMIndustry medianTTM
P/E TTM ↓Worst: 50,4Best: 26,8n/a42,1
Forward P/E ↓Best: 18,719,2Worst: 20,918,7
PEG ↓Best: 3,9Worst: 5,9n/a4,1
P/S TTM ↓Worst: 7,9Best: 6,56,76,6
EV/EBITDA ↓Worst: 26,9Best: 18,218,828,2
P/FCF ↓Worst: 27,624,8Best: 15,126,0

Price, %

  • ABBVn/a
  • AMGNn/a
  • GILDn/a

Returns

Best WorstNo mark — in between

PeriodABBVAMGNGILD
1 yearn/an/an/a
3 yearsn/an/an/a
5 yearsn/an/an/a
All timen/an/an/a

“Per year” is the average annual return: 90% growth over 3 years is 23,9% per year, not 30%. “All time” starts at the IPO, so only “per year” compares fairly. Prices adjusted for splits, dividends reinvested.

Analysts and insiders

Best WorstNo mark — in between

ABBVAMGNGILD
Share of “buy”82%Worst: 43%Best: 83%
Beat the forecastWorst: 2 of 4Best: 4 of 4Best: 4 of 4
Average “surprise”Worst: −0,1%Best: +8,7%+6,9%
Insiders over 12 monthssales $30,8 msales $26,7 msales $102 m

Details are on each stock page.